The Serotonin Transporter Availability for Prognosing Major Depressive Disorder (MDD) Treatment and Detecting MDD

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Major Depressive Disorder
Interventions
DRUG

Sertraline HCl

The regimen of Sertraline HCl will be administered with starting dose from minimum 25 mg/day for 1 week and maintenance dose of at least 50 mg/day up to 200 mg/day for the rest of 5 weeks.

OTHER

I-123-ADAM SPECT

The subjects underwent the SPECT scan after I-123-ADAM (185 MBq, 5mCi) IV injection.

All Listed Sponsors
collaborator

National Atomic Research Institute, Taiwan

OTHER

lead

Tri-Service General Hospital

OTHER

NCT02473783 - The Serotonin Transporter Availability for Prognosing Major Depressive Disorder (MDD) Treatment and Detecting MDD | Biotech Hunter | Biotech Hunter